nodes	percent_of_prediction	percent_of_DWPC	metapath
Sibutramine—CYP3A4—Temozolomide—brain cancer	0.18	0.486	CbGbCtD
Sibutramine—CYP3A4—Lomustine—brain cancer	0.153	0.414	CbGbCtD
Sibutramine—CYP3A4—Etoposide—brain cancer	0.037	0.0999	CbGbCtD
Sibutramine—SLC6A3—telencephalic ventricle—brain cancer	0.0149	0.132	CbGeAlD
Sibutramine—SLC6A3—ganglion—brain cancer	0.00928	0.0824	CbGeAlD
Sibutramine—SLC6A4—ganglion—brain cancer	0.0085	0.0755	CbGeAlD
Sibutramine—SLC6A2—ganglion—brain cancer	0.00749	0.0665	CbGeAlD
Sibutramine—SLC6A3—hindbrain—brain cancer	0.00704	0.0625	CbGeAlD
Sibutramine—SLC6A4—hindbrain—brain cancer	0.00645	0.0573	CbGeAlD
Sibutramine—SLC6A3—brainstem—brain cancer	0.00403	0.0358	CbGeAlD
Sibutramine—SLC6A4—brainstem—brain cancer	0.0037	0.0328	CbGeAlD
Sibutramine—SLC6A3—telencephalon—brain cancer	0.00358	0.0318	CbGeAlD
Sibutramine—SLC6A4—telencephalon—brain cancer	0.00328	0.0291	CbGeAlD
Sibutramine—SLC6A2—brainstem—brain cancer	0.00325	0.0289	CbGeAlD
Sibutramine—SLC6A2—telencephalon—brain cancer	0.00289	0.0256	CbGeAlD
Sibutramine—SLC6A3—midbrain—brain cancer	0.00257	0.0228	CbGeAlD
Sibutramine—SLC6A3—spinal cord—brain cancer	0.00251	0.0223	CbGeAlD
Sibutramine—SLC6A2—gonad—brain cancer	0.00241	0.0214	CbGeAlD
Sibutramine—SLC6A4—midbrain—brain cancer	0.00236	0.0209	CbGeAlD
Sibutramine—SLC6A4—spinal cord—brain cancer	0.0023	0.0204	CbGeAlD
Sibutramine—SLC6A2—medulla oblongata—brain cancer	0.00227	0.0201	CbGeAlD
Sibutramine—SLC6A3—head—brain cancer	0.00223	0.0198	CbGeAlD
Sibutramine—SLC6A4—endocrine gland—brain cancer	0.00207	0.0184	CbGeAlD
Sibutramine—SLC6A4—head—brain cancer	0.00204	0.0181	CbGeAlD
Sibutramine—SLC6A3—central nervous system—brain cancer	0.00203	0.0181	CbGeAlD
Sibutramine—SLC6A3—cerebellum—brain cancer	0.00199	0.0177	CbGeAlD
Sibutramine—SLC6A4—central nervous system—brain cancer	0.00186	0.0166	CbGeAlD
Sibutramine—SLC6A2—endocrine gland—brain cancer	0.00182	0.0162	CbGeAlD
Sibutramine—SLC6A2—head—brain cancer	0.0018	0.016	CbGeAlD
Sibutramine—SLC6A2—central nervous system—brain cancer	0.00164	0.0146	CbGeAlD
Sibutramine—SLC6A3—brain—brain cancer	0.00162	0.0143	CbGeAlD
Sibutramine—SLC6A4—brain—brain cancer	0.00148	0.0131	CbGeAlD
Sibutramine—SLC6A2—brain—brain cancer	0.0013	0.0116	CbGeAlD
Sibutramine—CYP3A4—endocrine gland—brain cancer	0.00101	0.009	CbGeAlD
Sibutramine—Pollakiuria—Temozolomide—brain cancer	0.000984	0.0019	CcSEcCtD
Sibutramine—Erectile dysfunction—Temozolomide—brain cancer	0.000981	0.0019	CcSEcCtD
Sibutramine—Thrombocytopenia—Procarbazine—brain cancer	0.000981	0.0019	CcSEcCtD
Sibutramine—Depression—Carmustine—brain cancer	0.00098	0.0019	CcSEcCtD
Sibutramine—Chills—Hydroxyurea—brain cancer	0.000979	0.00189	CcSEcCtD
Sibutramine—Tachycardia—Procarbazine—brain cancer	0.000977	0.00189	CcSEcCtD
Sibutramine—Photosensitivity reaction—Temozolomide—brain cancer	0.000972	0.00188	CcSEcCtD
Sibutramine—Weight increased—Temozolomide—brain cancer	0.000969	0.00187	CcSEcCtD
Sibutramine—Hyperhidrosis—Procarbazine—brain cancer	0.000968	0.00187	CcSEcCtD
Sibutramine—Renal failure—Carmustine—brain cancer	0.000966	0.00187	CcSEcCtD
Sibutramine—Alopecia—Hydroxyurea—brain cancer	0.000964	0.00187	CcSEcCtD
Sibutramine—Neuropathy peripheral—Carmustine—brain cancer	0.000963	0.00186	CcSEcCtD
Sibutramine—Hyperglycaemia—Temozolomide—brain cancer	0.00096	0.00186	CcSEcCtD
Sibutramine—Stomatitis—Carmustine—brain cancer	0.000958	0.00185	CcSEcCtD
Sibutramine—Urinary tract infection—Carmustine—brain cancer	0.000955	0.00185	CcSEcCtD
Sibutramine—Pneumonia—Temozolomide—brain cancer	0.000955	0.00185	CcSEcCtD
Sibutramine—Anorexia—Procarbazine—brain cancer	0.000955	0.00185	CcSEcCtD
Sibutramine—Depression—Temozolomide—brain cancer	0.000947	0.00183	CcSEcCtD
Sibutramine—Cardiac arrest—Etoposide—brain cancer	0.000937	0.00181	CcSEcCtD
Sibutramine—Nausea—Lomustine—brain cancer	0.000937	0.00181	CcSEcCtD
Sibutramine—Hypotension—Procarbazine—brain cancer	0.000936	0.00181	CcSEcCtD
Sibutramine—Neuropathy peripheral—Temozolomide—brain cancer	0.000931	0.0018	CcSEcCtD
Sibutramine—Stomatitis—Temozolomide—brain cancer	0.000925	0.00179	CcSEcCtD
Sibutramine—Urinary tract infection—Temozolomide—brain cancer	0.000923	0.00179	CcSEcCtD
Sibutramine—CYP3A4—central nervous system—brain cancer	0.000913	0.00811	CbGeAlD
Sibutramine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000912	0.00177	CcSEcCtD
Sibutramine—Insomnia—Procarbazine—brain cancer	0.000906	0.00175	CcSEcCtD
Sibutramine—Paraesthesia—Procarbazine—brain cancer	0.000899	0.00174	CcSEcCtD
Sibutramine—Sinusitis—Temozolomide—brain cancer	0.000891	0.00172	CcSEcCtD
Sibutramine—Somnolence—Procarbazine—brain cancer	0.00089	0.00172	CcSEcCtD
Sibutramine—Haemoglobin—Carmustine—brain cancer	0.000886	0.00171	CcSEcCtD
Sibutramine—Haemorrhage—Carmustine—brain cancer	0.000882	0.00171	CcSEcCtD
Sibutramine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000881	0.0017	CcSEcCtD
Sibutramine—Anaemia—Hydroxyurea—brain cancer	0.000878	0.0017	CcSEcCtD
Sibutramine—Hypoaesthesia—Carmustine—brain cancer	0.000877	0.0017	CcSEcCtD
Sibutramine—Decreased appetite—Procarbazine—brain cancer	0.000871	0.00168	CcSEcCtD
Sibutramine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000869	0.00168	CcSEcCtD
Sibutramine—Oedema peripheral—Carmustine—brain cancer	0.000869	0.00168	CcSEcCtD
Sibutramine—Haemoglobin—Temozolomide—brain cancer	0.000857	0.00166	CcSEcCtD
Sibutramine—Malaise—Hydroxyurea—brain cancer	0.000856	0.00166	CcSEcCtD
Sibutramine—Constipation—Procarbazine—brain cancer	0.000856	0.00166	CcSEcCtD
Sibutramine—Pain—Procarbazine—brain cancer	0.000856	0.00166	CcSEcCtD
Sibutramine—Haemorrhage—Temozolomide—brain cancer	0.000852	0.00165	CcSEcCtD
Sibutramine—Dysphagia—Etoposide—brain cancer	0.000852	0.00165	CcSEcCtD
Sibutramine—Leukopenia—Hydroxyurea—brain cancer	0.00085	0.00164	CcSEcCtD
Sibutramine—Visual impairment—Carmustine—brain cancer	0.00085	0.00164	CcSEcCtD
Sibutramine—Hypoaesthesia—Temozolomide—brain cancer	0.000848	0.00164	CcSEcCtD
Sibutramine—Pharyngitis—Temozolomide—brain cancer	0.000846	0.00164	CcSEcCtD
Sibutramine—Oedema peripheral—Temozolomide—brain cancer	0.00084	0.00162	CcSEcCtD
Sibutramine—Feeling abnormal—Procarbazine—brain cancer	0.000825	0.0016	CcSEcCtD
Sibutramine—Eye disorder—Carmustine—brain cancer	0.000824	0.00159	CcSEcCtD
Sibutramine—Convulsion—Hydroxyurea—brain cancer	0.000823	0.00159	CcSEcCtD
Sibutramine—Visual impairment—Temozolomide—brain cancer	0.000821	0.00159	CcSEcCtD
Sibutramine—Gastrointestinal pain—Procarbazine—brain cancer	0.000819	0.00158	CcSEcCtD
Sibutramine—Discomfort—Hydroxyurea—brain cancer	0.000799	0.00155	CcSEcCtD
Sibutramine—Eye disorder—Temozolomide—brain cancer	0.000796	0.00154	CcSEcCtD
Sibutramine—Urticaria—Procarbazine—brain cancer	0.000796	0.00154	CcSEcCtD
Sibutramine—Tinnitus—Temozolomide—brain cancer	0.000795	0.00154	CcSEcCtD
Sibutramine—Abdominal pain—Procarbazine—brain cancer	0.000792	0.00153	CcSEcCtD
Sibutramine—Body temperature increased—Procarbazine—brain cancer	0.000792	0.00153	CcSEcCtD
Sibutramine—Arrhythmia—Carmustine—brain cancer	0.000788	0.00152	CcSEcCtD
Sibutramine—Alopecia—Carmustine—brain cancer	0.000779	0.00151	CcSEcCtD
Sibutramine—Oedema—Hydroxyurea—brain cancer	0.000775	0.0015	CcSEcCtD
Sibutramine—Angiopathy—Temozolomide—brain cancer	0.000773	0.0015	CcSEcCtD
Sibutramine—Infection—Hydroxyurea—brain cancer	0.00077	0.00149	CcSEcCtD
Sibutramine—Immune system disorder—Temozolomide—brain cancer	0.00077	0.00149	CcSEcCtD
Sibutramine—Malnutrition—Carmustine—brain cancer	0.000768	0.00149	CcSEcCtD
Sibutramine—Chills—Temozolomide—brain cancer	0.000765	0.00148	CcSEcCtD
Sibutramine—Pneumonia—Etoposide—brain cancer	0.000764	0.00148	CcSEcCtD
Sibutramine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000759	0.00147	CcSEcCtD
Sibutramine—Alopecia—Temozolomide—brain cancer	0.000753	0.00146	CcSEcCtD
Sibutramine—Skin disorder—Hydroxyurea—brain cancer	0.000753	0.00146	CcSEcCtD
Sibutramine—Acute coronary syndrome—Etoposide—brain cancer	0.000749	0.00145	CcSEcCtD
Sibutramine—Renal failure—Etoposide—brain cancer	0.000747	0.00144	CcSEcCtD
Sibutramine—Myocardial infarction—Etoposide—brain cancer	0.000745	0.00144	CcSEcCtD
Sibutramine—Neuropathy peripheral—Etoposide—brain cancer	0.000745	0.00144	CcSEcCtD
Sibutramine—Back pain—Carmustine—brain cancer	0.000743	0.00144	CcSEcCtD
Sibutramine—Malnutrition—Temozolomide—brain cancer	0.000742	0.00144	CcSEcCtD
Sibutramine—Stomatitis—Etoposide—brain cancer	0.00074	0.00143	CcSEcCtD
Sibutramine—Anorexia—Hydroxyurea—brain cancer	0.000739	0.00143	CcSEcCtD
Sibutramine—Hypersensitivity—Procarbazine—brain cancer	0.000738	0.00143	CcSEcCtD
Sibutramine—Dysgeusia—Temozolomide—brain cancer	0.000727	0.00141	CcSEcCtD
Sibutramine—Vision blurred—Carmustine—brain cancer	0.000724	0.0014	CcSEcCtD
Sibutramine—Tremor—Carmustine—brain cancer	0.000719	0.00139	CcSEcCtD
Sibutramine—Asthenia—Procarbazine—brain cancer	0.000719	0.00139	CcSEcCtD
Sibutramine—Back pain—Temozolomide—brain cancer	0.000718	0.00139	CcSEcCtD
Sibutramine—Anaemia—Carmustine—brain cancer	0.00071	0.00137	CcSEcCtD
Sibutramine—Pruritus—Procarbazine—brain cancer	0.000709	0.00137	CcSEcCtD
Sibutramine—Agitation—Carmustine—brain cancer	0.000705	0.00136	CcSEcCtD
Sibutramine—Vision blurred—Temozolomide—brain cancer	0.000699	0.00135	CcSEcCtD
Sibutramine—Tremor—Temozolomide—brain cancer	0.000695	0.00134	CcSEcCtD
Sibutramine—Dyspnoea—Hydroxyurea—brain cancer	0.000691	0.00134	CcSEcCtD
Sibutramine—Somnolence—Hydroxyurea—brain cancer	0.000689	0.00133	CcSEcCtD
Sibutramine—Ill-defined disorder—Temozolomide—brain cancer	0.000688	0.00133	CcSEcCtD
Sibutramine—Leukopenia—Carmustine—brain cancer	0.000687	0.00133	CcSEcCtD
Sibutramine—Anaemia—Temozolomide—brain cancer	0.000686	0.00133	CcSEcCtD
Sibutramine—Diarrhoea—Procarbazine—brain cancer	0.000685	0.00133	CcSEcCtD
Sibutramine—Dyspepsia—Hydroxyurea—brain cancer	0.000682	0.00132	CcSEcCtD
Sibutramine—Agitation—Temozolomide—brain cancer	0.000682	0.00132	CcSEcCtD
Sibutramine—Hypoaesthesia—Etoposide—brain cancer	0.000679	0.00131	CcSEcCtD
Sibutramine—Angioedema—Temozolomide—brain cancer	0.000678	0.00131	CcSEcCtD
Sibutramine—Decreased appetite—Hydroxyurea—brain cancer	0.000674	0.0013	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000669	0.00129	CcSEcCtD
Sibutramine—Malaise—Temozolomide—brain cancer	0.000669	0.00129	CcSEcCtD
Sibutramine—Vertigo—Temozolomide—brain cancer	0.000667	0.00129	CcSEcCtD
Sibutramine—Convulsion—Carmustine—brain cancer	0.000665	0.00129	CcSEcCtD
Sibutramine—Leukopenia—Temozolomide—brain cancer	0.000664	0.00128	CcSEcCtD
Sibutramine—Hypertension—Carmustine—brain cancer	0.000663	0.00128	CcSEcCtD
Sibutramine—Pain—Hydroxyurea—brain cancer	0.000663	0.00128	CcSEcCtD
Sibutramine—Constipation—Hydroxyurea—brain cancer	0.000663	0.00128	CcSEcCtD
Sibutramine—Dizziness—Procarbazine—brain cancer	0.000662	0.00128	CcSEcCtD
Sibutramine—Palpitations—Temozolomide—brain cancer	0.000656	0.00127	CcSEcCtD
Sibutramine—Myalgia—Carmustine—brain cancer	0.000654	0.00126	CcSEcCtD
Sibutramine—Chest pain—Carmustine—brain cancer	0.000654	0.00126	CcSEcCtD
Sibutramine—Anxiety—Carmustine—brain cancer	0.000651	0.00126	CcSEcCtD
Sibutramine—Cough—Temozolomide—brain cancer	0.000647	0.00125	CcSEcCtD
Sibutramine—Convulsion—Temozolomide—brain cancer	0.000643	0.00124	CcSEcCtD
Sibutramine—Hypertension—Temozolomide—brain cancer	0.000641	0.00124	CcSEcCtD
Sibutramine—Feeling abnormal—Hydroxyurea—brain cancer	0.000639	0.00124	CcSEcCtD
Sibutramine—Eye disorder—Etoposide—brain cancer	0.000637	0.00123	CcSEcCtD
Sibutramine—Vomiting—Procarbazine—brain cancer	0.000637	0.00123	CcSEcCtD
Sibutramine—Confusional state—Carmustine—brain cancer	0.000632	0.00122	CcSEcCtD
Sibutramine—Myalgia—Temozolomide—brain cancer	0.000632	0.00122	CcSEcCtD
Sibutramine—Arthralgia—Temozolomide—brain cancer	0.000632	0.00122	CcSEcCtD
Sibutramine—Rash—Procarbazine—brain cancer	0.000631	0.00122	CcSEcCtD
Sibutramine—Dermatitis—Procarbazine—brain cancer	0.000631	0.00122	CcSEcCtD
Sibutramine—Anxiety—Temozolomide—brain cancer	0.000629	0.00122	CcSEcCtD
Sibutramine—Headache—Procarbazine—brain cancer	0.000627	0.00121	CcSEcCtD
Sibutramine—Oedema—Carmustine—brain cancer	0.000627	0.00121	CcSEcCtD
Sibutramine—Discomfort—Temozolomide—brain cancer	0.000624	0.00121	CcSEcCtD
Sibutramine—Infection—Carmustine—brain cancer	0.000622	0.0012	CcSEcCtD
Sibutramine—Angiopathy—Etoposide—brain cancer	0.000619	0.0012	CcSEcCtD
Sibutramine—Dry mouth—Temozolomide—brain cancer	0.000618	0.0012	CcSEcCtD
Sibutramine—Immune system disorder—Etoposide—brain cancer	0.000616	0.00119	CcSEcCtD
Sibutramine—Thrombocytopenia—Carmustine—brain cancer	0.000613	0.00119	CcSEcCtD
Sibutramine—Body temperature increased—Hydroxyurea—brain cancer	0.000613	0.00119	CcSEcCtD
Sibutramine—Chills—Etoposide—brain cancer	0.000612	0.00118	CcSEcCtD
Sibutramine—Tachycardia—Carmustine—brain cancer	0.000612	0.00118	CcSEcCtD
Sibutramine—Confusional state—Temozolomide—brain cancer	0.000611	0.00118	CcSEcCtD
Sibutramine—Oedema—Temozolomide—brain cancer	0.000605	0.00117	CcSEcCtD
Sibutramine—Anaphylactic shock—Temozolomide—brain cancer	0.000605	0.00117	CcSEcCtD
Sibutramine—Alopecia—Etoposide—brain cancer	0.000603	0.00117	CcSEcCtD
Sibutramine—Infection—Temozolomide—brain cancer	0.000602	0.00116	CcSEcCtD
Sibutramine—Anorexia—Carmustine—brain cancer	0.000597	0.00116	CcSEcCtD
Sibutramine—Nausea—Procarbazine—brain cancer	0.000595	0.00115	CcSEcCtD
Sibutramine—Thrombocytopenia—Temozolomide—brain cancer	0.000593	0.00115	CcSEcCtD
Sibutramine—Skin disorder—Temozolomide—brain cancer	0.000588	0.00114	CcSEcCtD
Sibutramine—Hypotension—Carmustine—brain cancer	0.000585	0.00113	CcSEcCtD
Sibutramine—Hyperhidrosis—Temozolomide—brain cancer	0.000585	0.00113	CcSEcCtD
Sibutramine—Dysgeusia—Etoposide—brain cancer	0.000581	0.00112	CcSEcCtD
Sibutramine—Anorexia—Temozolomide—brain cancer	0.000577	0.00112	CcSEcCtD
Sibutramine—Back pain—Etoposide—brain cancer	0.000574	0.00111	CcSEcCtD
Sibutramine—Hypersensitivity—Hydroxyurea—brain cancer	0.000571	0.0011	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000571	0.0011	CcSEcCtD
Sibutramine—Muscle spasms—Etoposide—brain cancer	0.000571	0.0011	CcSEcCtD
Sibutramine—Insomnia—Carmustine—brain cancer	0.000567	0.0011	CcSEcCtD
Sibutramine—Paraesthesia—Carmustine—brain cancer	0.000563	0.00109	CcSEcCtD
Sibutramine—Dyspnoea—Carmustine—brain cancer	0.000559	0.00108	CcSEcCtD
Sibutramine—Somnolence—Carmustine—brain cancer	0.000557	0.00108	CcSEcCtD
Sibutramine—Asthenia—Hydroxyurea—brain cancer	0.000556	0.00108	CcSEcCtD
Sibutramine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000552	0.00107	CcSEcCtD
Sibutramine—Ill-defined disorder—Etoposide—brain cancer	0.000551	0.00107	CcSEcCtD
Sibutramine—Anaemia—Etoposide—brain cancer	0.000549	0.00106	CcSEcCtD
Sibutramine—Insomnia—Temozolomide—brain cancer	0.000548	0.00106	CcSEcCtD
Sibutramine—Decreased appetite—Carmustine—brain cancer	0.000545	0.00105	CcSEcCtD
Sibutramine—Paraesthesia—Temozolomide—brain cancer	0.000544	0.00105	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Carmustine—brain cancer	0.000541	0.00105	CcSEcCtD
Sibutramine—Dyspnoea—Temozolomide—brain cancer	0.00054	0.00104	CcSEcCtD
Sibutramine—Somnolence—Temozolomide—brain cancer	0.000538	0.00104	CcSEcCtD
Sibutramine—Pain—Carmustine—brain cancer	0.000536	0.00104	CcSEcCtD
Sibutramine—Constipation—Carmustine—brain cancer	0.000536	0.00104	CcSEcCtD
Sibutramine—Malaise—Etoposide—brain cancer	0.000535	0.00104	CcSEcCtD
Sibutramine—Vertigo—Etoposide—brain cancer	0.000533	0.00103	CcSEcCtD
Sibutramine—Dyspepsia—Temozolomide—brain cancer	0.000533	0.00103	CcSEcCtD
Sibutramine—Leukopenia—Etoposide—brain cancer	0.000531	0.00103	CcSEcCtD
Sibutramine—Diarrhoea—Hydroxyurea—brain cancer	0.00053	0.00103	CcSEcCtD
Sibutramine—Decreased appetite—Temozolomide—brain cancer	0.000526	0.00102	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000523	0.00101	CcSEcCtD
Sibutramine—Loss of consciousness—Etoposide—brain cancer	0.000522	0.00101	CcSEcCtD
Sibutramine—Cough—Etoposide—brain cancer	0.000518	0.001	CcSEcCtD
Sibutramine—Pain—Temozolomide—brain cancer	0.000518	0.001	CcSEcCtD
Sibutramine—Constipation—Temozolomide—brain cancer	0.000518	0.001	CcSEcCtD
Sibutramine—Feeling abnormal—Carmustine—brain cancer	0.000516	0.000999	CcSEcCtD
Sibutramine—Convulsion—Etoposide—brain cancer	0.000514	0.000995	CcSEcCtD
Sibutramine—Hypertension—Etoposide—brain cancer	0.000513	0.000992	CcSEcCtD
Sibutramine—Dizziness—Hydroxyurea—brain cancer	0.000513	0.000992	CcSEcCtD
Sibutramine—Gastrointestinal pain—Carmustine—brain cancer	0.000512	0.000991	CcSEcCtD
Sibutramine—Chest pain—Etoposide—brain cancer	0.000505	0.000978	CcSEcCtD
Sibutramine—Discomfort—Etoposide—brain cancer	0.000499	0.000966	CcSEcCtD
Sibutramine—Feeling abnormal—Temozolomide—brain cancer	0.000499	0.000965	CcSEcCtD
Sibutramine—Body temperature increased—Carmustine—brain cancer	0.000495	0.000958	CcSEcCtD
Sibutramine—Abdominal pain—Carmustine—brain cancer	0.000495	0.000958	CcSEcCtD
Sibutramine—Gastrointestinal pain—Temozolomide—brain cancer	0.000495	0.000958	CcSEcCtD
Sibutramine—Vomiting—Hydroxyurea—brain cancer	0.000493	0.000953	CcSEcCtD
Sibutramine—Rash—Hydroxyurea—brain cancer	0.000489	0.000945	CcSEcCtD
Sibutramine—Confusional state—Etoposide—brain cancer	0.000489	0.000945	CcSEcCtD
Sibutramine—Dermatitis—Hydroxyurea—brain cancer	0.000488	0.000945	CcSEcCtD
Sibutramine—Headache—Hydroxyurea—brain cancer	0.000486	0.000939	CcSEcCtD
Sibutramine—Anaphylactic shock—Etoposide—brain cancer	0.000485	0.000937	CcSEcCtD
Sibutramine—Infection—Etoposide—brain cancer	0.000481	0.000931	CcSEcCtD
Sibutramine—Urticaria—Temozolomide—brain cancer	0.000481	0.000931	CcSEcCtD
Sibutramine—Abdominal pain—Temozolomide—brain cancer	0.000479	0.000926	CcSEcCtD
Sibutramine—Body temperature increased—Temozolomide—brain cancer	0.000479	0.000926	CcSEcCtD
Sibutramine—Thrombocytopenia—Etoposide—brain cancer	0.000474	0.000918	CcSEcCtD
Sibutramine—Tachycardia—Etoposide—brain cancer	0.000473	0.000915	CcSEcCtD
Sibutramine—Skin disorder—Etoposide—brain cancer	0.000471	0.00091	CcSEcCtD
Sibutramine—Hyperhidrosis—Etoposide—brain cancer	0.000468	0.000906	CcSEcCtD
Sibutramine—Anorexia—Etoposide—brain cancer	0.000462	0.000894	CcSEcCtD
Sibutramine—Hypersensitivity—Carmustine—brain cancer	0.000462	0.000893	CcSEcCtD
Sibutramine—Nausea—Hydroxyurea—brain cancer	0.00046	0.000891	CcSEcCtD
Sibutramine—Hypotension—Etoposide—brain cancer	0.000453	0.000876	CcSEcCtD
Sibutramine—Asthenia—Carmustine—brain cancer	0.00045	0.00087	CcSEcCtD
Sibutramine—Hypersensitivity—Temozolomide—brain cancer	0.000446	0.000863	CcSEcCtD
Sibutramine—Paraesthesia—Etoposide—brain cancer	0.000435	0.000842	CcSEcCtD
Sibutramine—Asthenia—Temozolomide—brain cancer	0.000434	0.00084	CcSEcCtD
Sibutramine—Dyspnoea—Etoposide—brain cancer	0.000432	0.000836	CcSEcCtD
Sibutramine—Somnolence—Etoposide—brain cancer	0.000431	0.000833	CcSEcCtD
Sibutramine—Diarrhoea—Carmustine—brain cancer	0.000429	0.000829	CcSEcCtD
Sibutramine—Pruritus—Temozolomide—brain cancer	0.000428	0.000829	CcSEcCtD
Sibutramine—Decreased appetite—Etoposide—brain cancer	0.000421	0.000815	CcSEcCtD
Sibutramine—Gastrointestinal disorder—Etoposide—brain cancer	0.000418	0.000809	CcSEcCtD
Sibutramine—Dizziness—Carmustine—brain cancer	0.000414	0.000802	CcSEcCtD
Sibutramine—Pain—Etoposide—brain cancer	0.000414	0.000802	CcSEcCtD
Sibutramine—Constipation—Etoposide—brain cancer	0.000414	0.000802	CcSEcCtD
Sibutramine—Diarrhoea—Temozolomide—brain cancer	0.000414	0.000801	CcSEcCtD
Sibutramine—Dizziness—Temozolomide—brain cancer	0.0004	0.000775	CcSEcCtD
Sibutramine—Feeling abnormal—Etoposide—brain cancer	0.000399	0.000772	CcSEcCtD
Sibutramine—Vomiting—Carmustine—brain cancer	0.000398	0.000771	CcSEcCtD
Sibutramine—Gastrointestinal pain—Etoposide—brain cancer	0.000396	0.000767	CcSEcCtD
Sibutramine—Rash—Carmustine—brain cancer	0.000395	0.000764	CcSEcCtD
Sibutramine—Dermatitis—Carmustine—brain cancer	0.000395	0.000764	CcSEcCtD
Sibutramine—Headache—Carmustine—brain cancer	0.000393	0.000759	CcSEcCtD
Sibutramine—Vomiting—Temozolomide—brain cancer	0.000385	0.000745	CcSEcCtD
Sibutramine—Urticaria—Etoposide—brain cancer	0.000385	0.000745	CcSEcCtD
Sibutramine—Body temperature increased—Etoposide—brain cancer	0.000383	0.000741	CcSEcCtD
Sibutramine—Abdominal pain—Etoposide—brain cancer	0.000383	0.000741	CcSEcCtD
Sibutramine—Rash—Temozolomide—brain cancer	0.000382	0.000739	CcSEcCtD
Sibutramine—Dermatitis—Temozolomide—brain cancer	0.000381	0.000738	CcSEcCtD
Sibutramine—Headache—Temozolomide—brain cancer	0.000379	0.000734	CcSEcCtD
Sibutramine—Nausea—Carmustine—brain cancer	0.000372	0.00072	CcSEcCtD
Sibutramine—Nausea—Temozolomide—brain cancer	0.00036	0.000696	CcSEcCtD
Sibutramine—Hypersensitivity—Etoposide—brain cancer	0.000357	0.000691	CcSEcCtD
Sibutramine—Asthenia—Etoposide—brain cancer	0.000348	0.000673	CcSEcCtD
Sibutramine—Pruritus—Etoposide—brain cancer	0.000343	0.000663	CcSEcCtD
Sibutramine—Diarrhoea—Etoposide—brain cancer	0.000332	0.000641	CcSEcCtD
Sibutramine—Dizziness—Etoposide—brain cancer	0.00032	0.00062	CcSEcCtD
Sibutramine—Vomiting—Etoposide—brain cancer	0.000308	0.000596	CcSEcCtD
Sibutramine—Rash—Etoposide—brain cancer	0.000305	0.000591	CcSEcCtD
Sibutramine—Dermatitis—Etoposide—brain cancer	0.000305	0.00059	CcSEcCtD
Sibutramine—Headache—Etoposide—brain cancer	0.000304	0.000587	CcSEcCtD
Sibutramine—Nausea—Etoposide—brain cancer	0.000288	0.000557	CcSEcCtD
